Gyros Protein Technologies and Cygnus Technologies Expand Collaboration to Support Improved Bioprocess Impurity Analytics, and Introduce HEK 293 HCP Assay Reagent Set for Gyrolab
Mesa Laboratories, Inc. (MLAB)
Last mesa laboratories, inc. earnings: 2/10 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
mesalabs.com/corporate
Company Research
Source: Business Wire
Collaboration is poised to deliver a range of ready-to-use bioprocess impurity reagent sets optimized for use with the Gyrolab platform New reagent set effectively detects host cell impurities from HEK 293 cells used in vaccine and viral vector manufacturing for cell and gene therapies, and vaccines UPPSALA, Sweden--(BUSINESS WIRE)--Gyros Protein Technologies (part of Mesa Labs’ Biopharmaceutical Development Division), a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, today announced the next phase of its on-going collaboration with Cygnus Technologies, a Maravai LifeSciences company, and the introduction of a new HEK 293 HCP immunoassay solution. The Cygnus HEK 293 HCP Assay Reagent Set for Gyrolab® is the first of a planned range of ready-to-use bioprocess impurity reagent sets optimized for use with the Gyrolab platform to be developed by Cygnus as part of the expanded collaboration.The extension of the collaboration
Show less
Read more
Impact Snapshot
Event Time:
MLAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MLAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MLAB alerts
High impacting Mesa Laboratories, Inc. news events
Weekly update
A roundup of the hottest topics
MLAB
News
- The past three years for Mesa Laboratories (NASDAQ:MLAB) investors has not been profitable [Yahoo! Finance]Yahoo! Finance
- Andvari Associates Q1 2024 Letter [Seeking Alpha]Seeking Alpha
- MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTESGlobeNewswire
- MESA LABS DECLARES QUARTERLY DIVIDENDGlobeNewswire
- Mesa Laboratories, Inc. (NASDAQ: MLAB) had its price target raised by analysts at Evercore ISI from $124.00 to $130.00. They now have an "outperform" rating on the stock.MarketBeat
MLAB
Earnings
- 2/5/24 - Beat
MLAB
Analyst Actions
- 4/4/24 - Evercore ISI Group
MLAB
Sec Filings
- 4/8/24 - Form 8-K
- 4/3/24 - Form 4
- 4/3/24 - Form 4
- MLAB's page on the SEC website